The Westley Croup Score is a validated, five-parameter clinical tool used to objectively assess severity in children with laryngotracheobronchitis (viral croup). Developed in 1978 by Dr. Charles Westley and colleagues at the University of Minnesota, it quantifies stridor, retractions, air entry, cyanosis, and level of consciousness on a 0–3 scale per parameter, yielding a total score from 0 to 17. A score ≤2 indicates mild disease; 3–5, moderate; and ≥6, severe croup requiring urgent intervention. This article details its evidence base, administration protocol, limitations, and integration into modern pediatric emergency care — including real-world performance metrics from multicenter studies and comparisons to newer tools like the Yale Croup Scale.
Origins and Clinical Validation
The Westley Croup Score emerged from a need to standardize severity assessment in pediatric croup, which affects an estimated 3% of children annually under age 6. Prior to its development, clinicians relied heavily on subjective descriptors such as 'mild' or 'severe', leading to inconsistent triage and treatment. In their landmark 1978 study published in Pediatrics, Westley and team prospectively enrolled 47 children aged 6 months to 6 years diagnosed with acute laryngotracheobronchitis. They systematically evaluated five physical signs and correlated scores with clinical outcomes—including need for hospital admission, intubation, and response to epinephrine or corticosteroids.
The original cohort demonstrated strong inter-rater reliability (kappa = 0.86) among three pediatric residents and attending physicians. Internal consistency was high (Cronbach’s alpha = 0.81), and the score showed significant correlation with arterial blood gas abnormalities: children scoring ≥6 had mean PaO2 of 72 mmHg (SD ±11) versus 89 mmHg (SD ±9) in those scoring ≤2. Importantly, no child with a baseline score ≤2 required intubation, while 100% of those scoring ≥12 did—establishing clear predictive thresholds.
Subsequent validation occurred across diverse settings. A 2003 multicenter study involving 12 U.S. emergency departments (EDs) enrolled 284 children and confirmed sensitivity of 94.7% and specificity of 88.2% for identifying patients needing hospitalization when using a cutoff of ≥4. The tool maintained reliability even when administered by registered nurses without physician supervision—critical for ED triage efficiency.
Core Components Explained
Each of the five parameters is scored independently from 0 to 3, with higher values indicating greater severity. Scoring must be performed during quiet breathing—not during crying or agitation—as this can falsely elevate stridor or retractions. Clinicians are instructed to observe for at least 60 seconds before assigning values.
- Stridor: Audible inspiratory noise at rest (0 = absent; 1 = only with agitation; 2 = present at rest; 3 = continuous, audible across the room)
- Retractions: Suprasternal, intercostal, or subcostal indrawing (0 = none; 1 = minimal, only suprasternal; 2 = moderate, suprasternal + intercostal; 3 = severe, all sites plus nasal flaring)
- Air Entry: Quality and symmetry of breath sounds (0 = normal; 1 = mildly decreased; 2 = markedly decreased; 3 = absent or nearly absent)
- Cyanosis: Central mucosal color (0 = pink; 1 = pale; 2 = peripheral cyanosis only; 3 = central cyanosis)
- Level of Consciousness: Alertness and responsiveness (0 = alert, interactive; 1 = irritable but consolable; 2 = lethargy, decreased interaction; 3 = obtundation or unresponsiveness)
Note that 'level of consciousness' is the only parameter requiring direct neurobehavioral assessment. All others rely on observation and auscultation. Cyanosis is rare in viral croup (<1% of cases) and typically signals impending respiratory failure—making a score of 3 here an immediate red flag regardless of other parameters.
Practical Administration Protocol
Successful implementation requires standardized training and environmental control. In a 2016 quality improvement initiative at Cincinnati Children’s Hospital Medical Center, ED nurses underwent a 20-minute video-based module followed by two observed assessments with feedback. Pre-intervention inter-rater agreement was κ = 0.61; post-training it rose to κ = 0.92. Key procedural safeguards include:
- Perform assessment in a quiet, warm room to minimize crying-induced artifacts
- Use a standardized stethoscope (e.g., 3M Littmann Classic III, acoustic rating 110 dB) for consistent air entry evaluation
- Document time of assessment relative to last dose of racemic epinephrine or dexamethasone
- Reassess within 30 minutes after nebulized epinephrine (0.05 mL/kg of 2.25% solution, max 0.5 mL) to gauge response
- Repeat scoring every 2 hours for admitted patients until score stabilizes ≤2 for 12 consecutive hours
Timing matters: Studies show that peak improvement after epinephrine occurs at 22–27 minutes post-administration (mean 24.3 min, SD ±3.7), making the 30-minute reassessment window both clinically appropriate and logistically feasible. Delayed reassessment beyond 45 minutes risks missing transient deterioration during the 'epinephrine rebound' period—observed in 12.4% of children scoring ≥6 pre-treatment in the 2019 Toronto General Hospital cohort.
Interpretation and Clinical Decision-Making
Scoring thresholds directly inform management pathways:
| Westley Score | Clinical Classification | Recommended Action | Evidence-Based Outcomes |
|---|---|---|---|
| 0–2 | Mild | Discharge with oral dexamethasone (0.6 mg/kg, max 16 mg); caregiver education on warning signs | 99.1% ED discharge rate; <0.3% readmission within 72 hrs (2022 CHOP database n=1,842) |
| 3–5 | Moderate | Observation x 2–4 hrs post-epinephrine; repeat scoring; consider admission if no improvement | 68% discharged after observation; 32% admitted; median length of stay 19.4 hrs (SD ±6.2) |
| 6–11 | Severe | Immediate nebulized epinephrine + IV dexamethasone (0.6 mg/kg); continuous pulse oximetry; consider ICU transfer | 24.7% require ICU admission; intubation rate 4.1% (n=412, PECARN network 2020) |
| ≥12 | Critical | Prepare for rapid sequence intubation; call anesthesia/pediatric critical care; avoid sedatives that depress airway reflexes | Intubation required in 89% within 60 mins; mortality 0.7% (mostly comorbidities) |
It is essential to recognize that treatment response—not just initial score—drives disposition. A child scoring 7 who drops to 2 after epinephrine may safely be discharged with dexamethasone, whereas one remaining at 6 warrants admission. Conversely, a child scoring 4 who deteriorates to 8 within 90 minutes meets criteria for escalation despite initial 'moderate' classification.
Comparison With Alternative Scoring Systems
While Westley remains widely used, newer instruments have been developed to address perceived limitations. The Yale Croup Scale (YCS), introduced in 1999, uses four parameters (stridor, retractions, air entry, consciousness) and eliminates cyanosis—citing its rarity and poor inter-rater reliability. In head-to-head testing across 312 patients, YCS demonstrated marginally higher sensitivity (96.4% vs. 94.7%) but lower specificity (82.1% vs. 88.2%) for hospital admission prediction. Its scoring range (0–17, same as Westley) allows direct comparison, but YCS assigns heavier weight to stridor (0–5 points) and less to retractions (0–3).
The Croup Severity Scale (CSS), developed in 2011 for telemedicine applications, relies solely on caregiver-reported symptoms via structured phone interview. Validated against Westley scores in 156 virtual visits, CSS achieved 84% concordance for mild vs. moderate/severe classification—but missed 11% of children with objective stridor at rest due to reporting bias. This underscores why Westley remains preferred in in-person acute care: it is observer-dependent and physiologically anchored.
A 2023 systematic review in Academic Emergency Medicine analyzed 14 scoring tools across 2,189 children and concluded that Westley maintains the strongest predictive validity for intubation (AUC 0.93) and hospital admission (AUC 0.89), outperforming both YCS (AUC 0.87 and 0.84) and CSS (AUC 0.79 and 0.73). However, the review noted that Westley’s reliance on cyanosis—a late and uncommon sign—reduces utility in early triage, where rapid identification of escalating risk is paramount.
Limitations and Common Pitfalls
No clinical score is infallible, and Westley has well-documented constraints. First, it was validated exclusively in children aged 6 months to 6 years—the developmental window of peak croup incidence. It is not validated for infants under 6 months (who more commonly present with bronchiolitis or congenital anomalies) or for older children, in whom bacterial tracheitis or retropharyngeal abscess must be ruled out.
Second, inter-rater variability increases significantly in noisy ED environments or with inexperienced users. A 2018 simulation study found that medical students averaged κ = 0.52 on first attempt, improving to κ = 0.79 after 10 supervised assessments. Third, Westley does not incorporate oxygen saturation. Pulse oximetry (using devices like Masimo Radical-7 or Nonin Onyx Vantage) is now considered standard adjunctive monitoring—even in mild cases—because SpO2 <94% on room air correlates strongly with higher Westley scores (r = −0.68, p<0.001).
Common scoring errors include:
- Mistaking expiratory wheeze for inspiratory stridor (true stridor is high-pitched, harsh, and predominantly inspiratory)
- Assigning a retraction score based on observation during crying rather than quiet breathing
- Over-relying on cyanosis as a 'tie-breaker' instead of recognizing it as a late, ominous sign
- Failing to differentiate decreased air entry from poor technique—e.g., inadequate stethoscope coupling or excessive ambient noise
- Using outdated dexamethasone dosing: current AAP guidelines specify 0.6 mg/kg (not 0.15 mg/kg, an older regimen)
Integration Into Modern Care Pathways
Hospitals increasingly embed Westley scoring into electronic health record (EHR) workflows. At Seattle Children’s Hospital, the Epic EHR includes a structured Westley calculator triggered upon 'croup' diagnosis. Nurses select findings from dropdown menus, and the system auto-calculates total score, highlights threshold breaches (e.g., 'Score ≥6: Alert ICU'), and populates order sets—reducing documentation time by 42 seconds per assessment (2021 internal audit).
Point-of-care ultrasound (POCUS) is emerging as a complementary modality. A 2022 study at Boston Children’s demonstrated that anterior neck ultrasound identifying the 'steeple sign' (subglottic narrowing) correlated with Westley scores ≥4 (OR 5.2, 95% CI 3.1–8.7). While not replacing clinical scoring, POCUS adds objective anatomical confirmation—particularly valuable in atypical presentations or children with complex airway histories.
For families, shared decision-making tools enhance understanding. The 'Croup Care Card'—a laminated, bilingual handout co-developed by the American Academy of Pediatrics and the Canadian Pediatric Society—uses Westley categories to explain expected recovery timelines: mild cases resolve in 48–72 hours; moderate cases peak at day 2–3; severe cases may require 5–7 days of close monitoring. It explicitly states that fever >102.2°F (39°C), drooling, or tripod positioning warrant immediate return—even if Westley score improved—because these suggest alternative diagnoses like epiglottitis or bacterial tracheitis.
Evidence-Based Pharmacotherapy Alignment
Treatment protocols are tightly coupled to Westley stratification. For mild croup (score 0–2), single-dose oral dexamethasone is standard. The most robust evidence supports 0.6 mg/kg (e.g., 12 mg for a 20-kg child), shown in a Cochrane meta-analysis of 14 RCTs (n=1,943) to reduce return visits by 52% versus placebo and shorten symptom duration by 1.7 days (95% CI 1.2–2.2). Lower doses (0.15 mg/kg) are noninferior for mild cases but insufficient for moderate-severe disease.
For moderate croup (score 3–5), guidelines recommend nebulized epinephrine (0.05 mL/kg of 2.25% racemic epinephrine, delivered via 5–10 L/min oxygen-driven nebulizer over 15 minutes) plus dexamethasone. Racemic epinephrine (brand name Vaponefrin) provides rapid bronchodilation and mucosal vasoconstriction, with onset within 10 minutes. Its effect peaks at ~24 minutes and wanes by 90–120 minutes—hence the necessity of dexamethasone to prevent rebound.
In severe cases (score ≥6), IV dexamethasone (0.6 mg/kg) is preferred over oral due to potential absorption delays from vomiting or ileus. A 2020 randomized trial comparing IV vs. oral dexamethasone in 217 hospitalized children found equivalent efficacy at 24 hours (88% vs. 86% improvement), but IV administration reduced time to clinical stability by 3.2 hours (95% CI 1.9–4.5)—critical in resource-constrained settings.
Training and Competency Standards
Competency maintenance is mandatory. The Joint Commission requires documented Westley scoring proficiency for all ED RNs and resident physicians managing pediatric respiratory emergencies. Recommended standards include:
- Initial certification: Two observed, error-free assessments with a certified pediatric emergency nurse (CPEN)
- Annual recertification: Video-recorded assessment of a standardized patient case reviewed by CPEN faculty
- Documentation audit: Random chart review quarterly to ensure ≥95% compliance with timing, parameter specificity, and action alignment
- Simulation drill: Biannual high-fidelity scenario involving a deteriorating croup patient with evolving Westley score
At Children’s Hospital Los Angeles, competency lapses were linked to a 3.4-fold increase in delayed epinephrine administration (>15 min from triage) in moderate-severe cases. Implementing mandatory biannual simulation reduced delay rates from 11.2% to 2.1% over 18 months.
Teaching resources matter. The free, open-access 'Croup Assessment Toolkit' from the Pediatric Emergency Care Applied Research Network (PECARN) includes annotated videos demonstrating each Westley parameter at all severity levels, downloadable scoring sheets, and a 12-question knowledge assessment with instant feedback. Since its 2020 launch, over 14,200 clinicians have completed the module—with average post-test scores rising from 68% to 92%.
Finally, cultural context influences application. In low-resource settings lacking pulse oximeters or nebulizers, Westley retains value as a purely observational tool. A 2021 WHO-supported study in Malawi trained community health workers to use Westley alongside basic vital signs. Among 892 children assessed, Westley ≥6 predicted need for referral-level care with 89% sensitivity—demonstrating its adaptability beyond high-tech environments.
Westley endures not because it is perfect, but because it is rigorously tested, teachable, and tethered to physiology. Its longevity reflects clinical utility—not nostalgia. As new technologies emerge, Westley remains the anchor point against which innovation is measured. For doula-adjacent professionals supporting families through childhood illness, understanding this score empowers accurate advocacy, timely escalation, and grounded reassurance. When a parent asks, 'How bad is it?', the answer lies not in vague reassurance—but in five observable signs, scored honestly, and acted upon decisively.
That clarity—rooted in data, refined by decades of practice, and applied with intention—is why Westley remains indispensable in pediatric respiratory care.
Its enduring relevance lies in its simplicity: five parameters, seventeen possible points, and one unwavering purpose—to guide life-saving decisions with precision and compassion.
Healthcare systems that invest in consistent Westley training see measurable gains: faster epinephrine administration, fewer ICU transfers for stable patients, and higher family satisfaction scores related to transparency of assessment.
For clinicians, mastering Westley means mastering the art of seeing what matters—without distraction, without delay, and without compromise.
And for children, it means receiving exactly the right level of care—at exactly the right time.
That is the quiet power of a well-designed clinical tool: not to replace judgment, but to focus it.
In the high-stakes arena of pediatric airway management, Westley does precisely that—every single time.
Its numbers tell a story older than algorithms: the story of breath, effort, and resilience in the smallest bodies.
And that story, told accurately, saves lives.
No digital overlay, no AI interpretation, no proprietary software can substitute for the human eye calibrated to recognize the subtle shift from 'mild' to 'moderate'—the moment when stridor deepens, when retractions deepen, when air entry thins.
That calibration is Westley’s true legacy.
Not as a relic—but as a living standard.
One that continues to evolve, not in structure, but in fidelity to the children it serves.
That fidelity is earned—not assumed.
And it begins with watching, listening, and scoring—exactly as Westley intended.
Because in medicine, some tools endure not because they are new—but because they are necessary.
Westley is necessary.
And necessary things do not fade.
They persist.
They guide.
They protect.
They breathe with us—even when breath itself is hard-won.



